Home
About
Overview
Sharing Data
ORCID
Help
History (1)
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
An open-label, 6-month study of allopurinol safety in gout: The LASSO study. Semin Arthritis Rheum. 2015 Oct; 45(2):174-83.
View in:
PubMed
subject areas
Adult
Aged
Allopurinol
Anti-Inflammatory Agents, Non-Steroidal
Colchicine
Female
Gout
Gout Suppressants
Humans
Male
Middle Aged
Treatment Outcome
Uric Acid
authors with profiles
Michael A. Becker